These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 9157992)

  • 1. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
    Lansing TJ; Turk BF; Kanner SB; Gilmer TM
    Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
    Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
    Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
    Gilmer TM; Lamb PW; Oshimura M; Barrett JC
    Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel tyrosine phosphorylations accompany the activation of pp60c-src during chemical carcinogenesis.
    Kanner SB; Gilmer TM; Reynolds AB; Parsons JT
    Oncogene; 1989 Mar; 4(3):295-300. PubMed ID: 2468123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
    MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
    Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src.
    Bagrodia S; Chackalaparampil I; Kmiecik TE; Shalloway D
    Nature; 1991 Jan; 349(6305):172-5. PubMed ID: 1702522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
    Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
    Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
    Thomassen DG; Gilmer TM; Annab LA; Barrett JC
    Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
    Tanaka A; Salem M; Eckroade RJ; Fujita DJ
    Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
    Maroney AC; Qureshi SA; Foster DA; Brugge JS
    Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells.
    Takenouchi Y; Oo ML; Senga T; Watanabe Y; Machida K; Miyazaki K; Nimura Y; Hamaguchi M
    Oncol Rep; 2004 May; 11(5):1059-62. PubMed ID: 15069547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of mouse cells by wild-type mouse c-Src.
    Lin PH; Shenoy S; Galitski T; Shalloway D
    Oncogene; 1995 Jan; 10(2):401-5. PubMed ID: 7530829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation.
    Hirsch DS; Shen Y; Dokmanovic M; Wu WJ
    Cancer Res; 2010 Jul; 70(14):5974-83. PubMed ID: 20551057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating SRC mutation in a subset of advanced human colon cancers.
    Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
    Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
    Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
    Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
    Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
    Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.